Value Microcaps Motherboard

[cliffvb]

VPHM is also a tough one for me to figure out here.

On the plus side, Vancocin orders and profits are very strong plus the company has interests in several more drugs that I expect will enhance their bottom line down the road.

On the negative side, Vancocin has no patent protection anymore and as the demand and profits increase the company is more and more likely to see some competition down the road. Also I don't like their 25 year capitalization of the cost of it. Negative tangible BV and a rather rich premium of P/S ratio also has me concerned.

Bottom line: I'm still long but I also have recently cashed in about 2/3 of my shares. While I still consider that the company has a slight positive risk/ reward ratio, I am seeking better opportunities elsewhere. Still it has the ingredients to catch the market's fancy and could continue to catapult far above present levels. The "value" investor in me has pulled my reins in however.

THANKS MSGI for pointing this one out back when it was in in the low single digits!